Pharmaceutical group · Germany
Medac
A group of 11 companies with 162 medicines in 7 countries.
Group structure
11 companies in 6 countries
Loading your page…
Loading your page…
Pharmaceutical group · Germany
A group of 11 companies with 162 medicines in 7 countries.
11 companies in 6 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 162
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABIRATERONE MEDACCompressa rivestita con film | Abiraterone | Italy | Authorised | |
| AMBRISENTAN MEDACCompressa rivestita con film | Ambrisentan | Italy | Authorised | |
| APREMILAST MEDACCompressa rivestita con film | Apremilast | Italy | Authorised | |
| Arsenic trioxide medac | Arsenicum album | EU (EMA) | Authorised | 2020 |
| Arsenic trioxide medac 1 mg/ml concentraat voor oplossing voor infusieConcentraat voor oplossing voor infusie | Arsenicum album | Netherlands | Authorised | 2020 |
| BCG MEDACPolvere e solvente per sospensione endovescicale | Bcg vaccine | Italy | Authorised | |
| BCG-medac, poeder en oplosmiddel voor suspensie voor intravesicaal gebruikPoeder voor blaasspoeling | Bcg vaccine | Netherlands | Authorised | 2002 |
| BCG-medac prašak i otapalo za intravezikalnu suspenzijuprašak i otapalo za intravezikalnu suspenziju | Bakterija bcg (bacillus calmette gué, Rin), soj rivm | Croatia | Marketed | 2019 |
| BENDAMUSTINA MEDACPolvere per concentrato e soluzione per soluzione per infusione | Bendamustine | Italy | Authorised | |
| Bendamustine HCl medac 2,5 mg/ml, poeder voor concentraat voor oplossing voor infusiePoeder voor concentraat voor oplossing voor infusie | Bendamustine | Netherlands | Authorised | 2016 |
| Bleomedac, poeder voor oplossing voor injectie 15000 IU (Ph. Eur.)Poeder voor oplossing voor injectie | Bleomycin | Netherlands | Authorised | 2011 |
| BORTEZOMIB MEDACPolvere per soluzione iniettabile | Bortezomib | Italy | Authorised | |
| Bortezomib medac 1 mg, poeder voor oplossing voor injectiePoeder voor oplossing voor injectie | Bortezomib | Netherlands | Authorised | 2015 |
| Bortezomib medac 2,5 mg, poeder voor oplossing voor injectiePoeder voor oplossing voor injectie | Bortezomib | Netherlands | Authorised | 2019 |
| Bortezomib medac 3,5 mg poeder voor oplossing voor injectiePoeder voor oplossing voor injectie | Bortezomib | Netherlands | Authorised | 2015 |
| CAPECITABINA MEDACCompressa rivestita con film | Capecitabine | Italy | Authorised | |
| Capecitabine Medac | Capecitabine | EU (EMA) | Authorised | 2012 |
| Capecitabine medac 150 mg filmomhulde tabletFilmomhulde tablet | Capecitabine | Netherlands | Authorised | 2012 |
| Capecitabine medac 300 mg filmomhulde tabletFilmomhulde tablet | Capecitabine | Netherlands | Authorised | 2012 |
| Capecitabine medac 500 mg filmomhulde tabletFilmomhulde tablet | Capecitabine | Netherlands | Authorised | 2012 |
| CARBOPLATINO MEDACConcentrato per soluzione per infusione | Carboplatin | Italy | Authorised | |
| CARMUSTINA MEDACPolvere e solvente per soluzione per infusione endovenosa | Carmustine | Italy | Authorised | |
| CARMUSTINA MEDAC 100 MG POLVO Y DISOLVENTE PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG100 mg · Polvo y disolvente para solución para perfusión | Carmustine | Spain | Marketed | 2020 |
| Carmustine medac 100 mg poeder en oplosmiddel voor concentraat voor oplossing voor infusiePoeder en oplosmiddel voor oplossing voor infusie | Carmustine | Netherlands | Authorised | 2018 |
| Carmustine medac (previously Carmustine Obvius) | Carmustine | EU (EMA) | Authorised | 2018 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 59 | 37 | 22 | CompaniesAll medicines |
| Netherlands | 57 | 57 | 0 | CompaniesAll medicines |
| Italy | 29 | 29 | 0 | CompaniesAll medicines |
| European Union (EMA) | 11 | 8 | 3 | CompaniesAll medicines |
| Saudi Arabia | 4 | 4 | 0 | CompaniesAll medicines |
| Croatia | 1 | 1 | 0 | CompaniesAll medicines |
| Romania | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil, France, Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Report an error or request removalCorrections from the company itself are welcome.
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.